Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Device user regulations, not user friendly.

J Cooney

    AOHA : a Publication of the American Osteopathic Hospital Association
    |May 9, 1991
    PubMed
    Summary
    This summary is machine-generated.

    The Food and Drug Administration (FDA) sought feedback on the Safe Medical Devices Act of 1990. However, the agency received more questions than comments from healthcare organizations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Flow properties of single origin chocolates: Effect of product formulation and particle size.

    Journal of food science·2024
    Same author

    The use of predator tags to explain reversal movement patterns in Atlantic salmon smolts (Salmo salar L.).

    Journal of fish biology·2024
    Same author

    Co-prescribing of linezolid and serotonergic agents in a general hospital setting.

    Irish journal of psychological medicine·2018
    Same author

    Mindfulness-based cognitive therapy for psycho-oncology patients: an exploratory study.

    Irish journal of psychological medicine·2018
    Same author

    All is not lost in accelerated phase/blast crisis and after tyrosine kinase inhibitors fail in chronic myeloid leukaemia: a retrospective study of allogeneic stem cell transplant outcomes in Australia and New Zealand.

    Bone marrow transplantation·2016
    Same author

    Red cell and platelet transfusion burden following myeloablative allogeneic haemopoietic stem cell transplantation.

    Internal medicine journal·2015
    Same journal

    Doctors Hospital chair Costin stresses active role of DOs on boards.

    AOHA : a publication of the American Osteopathic Hospital Association·1992
    Same journal

    Vincent leads Doctors Hospital, Columbus, in programs to adapt to community needs.

    AOHA : a publication of the American Osteopathic Hospital Association·1992
    Same journal

    Judge stresses community involvement key to success at Community Hospital of Lancaster.

    AOHA : a publication of the American Osteopathic Hospital Association·1992
    Same journal

    Chairman Michael Roman puts quality first.

    AOHA : a publication of the American Osteopathic Hospital Association·1992
    Same journal

    CHS strengthens commitment to osteopathic hospitals with Pinellas Park acquisition.

    AOHA : a publication of the American Osteopathic Hospital Association·1992
    Same journal

    Union's chair, Bonjavanni: concern for the community is central to trustee role.

    AOHA : a publication of the American Osteopathic Hospital Association·1992
    See all related articles

    Area of Science:

    • Regulatory Affairs
    • Medical Device Safety
    • Public Health Policy

    Background:

    • The Safe Medical Devices Act of 1990 mandated reporting of adverse events for medical devices.
    • The Food and Drug Administration (FDA) is responsible for regulating medical devices in the United States.

    Purpose of the Study:

    • To assess the effectiveness of the FDA's outreach to healthcare organizations regarding the Safe Medical Devices Act of 1990.
    • To understand the level of engagement and identify areas of confusion among healthcare organizations concerning medical device reporting.

    Main Methods:

    • The FDA solicited input from healthcare organizations through a formal invitation.
    • Analysis of the submitted responses to categorize them as either comments or questions.

    Related Experiment Videos

    Main Results:

    • The FDA received a higher volume of questions compared to substantive comments from healthcare organizations.
    • This indicates potential areas of uncertainty or a need for further clarification regarding the Safe Medical Devices Act of 1990.

    Conclusions:

    • Healthcare organizations may require additional guidance and resources to fully understand and comply with the Safe Medical Devices Act of 1990.
    • Future FDA outreach efforts should prioritize addressing the specific questions raised by healthcare organizations to improve compliance and device safety.